STLN insider filings

Starling Oncology, Inc. — 9 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen STLN transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 8 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Chernett Jorey — 10% owner31 leg · 48,294 sh · $176,2731 leg · 2,851,061 sh · $11,375,7336
Hively Brad — Director1—1 leg · 298,853 sh · $1,946,310—
Podnos Yale — Chief Medical Officer2——2
Carter Robert Ross — Chief Financial Officer1——1
Virnich Daniel — Chief Executive Officer1——1

Recent insider filings — Starling Oncology, Inc.

FiledFormInsiderReported transactionsSource
2026-11-194Virnich Daniel — Chief Executive OfficerOther (J): 5,102 @ $3.40EDGAR
2026-11-194Carter Robert Ross — Chief Financial OfficerOther (J): 138 @ $3.40EDGAR
2026-11-194Podnos Yale — Chief Medical OfficerOther (J): 1,271 @ $3.40EDGAR
2026-11-174Podnos Yale — Chief Medical OfficerOther (J): 770 @ $3.76EDGAR
2026-11-134/AChernett Jorey — 10% ownerPurchase (P): 1,391 (derivative) @ $0.80EDGAR
2026-11-124Chernett Jorey — 10% ownerPurchase (P): 1,391 (derivative) @ $0.80EDGAR
2026-11-104Chernett Jorey — 10% ownerSale (S): 2,851,061 @ $3.99 · Purchase (P): 48,294 @ $3.65 · Purchase (P): 10,000 (derivative) @ $0.07 · Purchase (P): 5,000 (derivative) @ $0.40 · Purchase (P): 7,500 (derivative) @ $0.54 · Purchase (P): 7,000 (derivative) @ $0.67EDGAR
2026-08-244Hively Brad — DirectorSale (S): 298,853 @ $6.51EDGAR
2026-08-174Chernett Jorey — 10% ownerPurchase (P): 12,000 @ $6.54 · Sale (S): 100 (derivative) @ $6.24EDGAR

Recent 8-K events — Starling Oncology, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-128-K/A7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-218-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-038-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-078-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-228-K?
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=STLN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs